Cyclodextrins in non-viral gene delivery

被引:103
|
作者
Lai, Wing-Fu [1 ]
机构
[1] Yonsei Univ, Coll Dent, Dept Oral Biol, Div Anat & Dev Biol, Seoul 120749, South Korea
关键词
Cyclodextrin; Gene delivery; Non-viral vector; Polymer; Transfection; NUCLEIC-ACID DELIVERY; BETA-CYCLODEXTRIN; ALPHA-CYCLODEXTRIN; IN-VIVO; POLYAMIDOAMINE DENDRIMER; OLIGONUCLEOTIDE DELIVERY; PLASMID DNA; PHARMACEUTICAL APPLICATIONS; ABSORPTION ENHANCER; CONTAINING POLYMERS;
D O I
10.1016/j.biomaterials.2013.09.061
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cyclodextrins (CDs) are naturally occurring cyclic oligosaccharides. They consist of (alpha-1,4)-linked glucose units, and possess a basket-shaped topology with an "inner-outer" amphiphilic character. Over the years, substantial efforts have been undertaken to investigate the possible use of CDs in drug delivery and controlled drug release, yet the potential of CDs in gene delivery has received comparatively less discussion in the literature. In this article, we will first discuss the properties of CDs for gene delivery, followed by a synopsis of the use of CDs in development and modification of non-viral gene carriers. Finally, areas that are noteworthy in CD-based gene delivery will be highlighted for future research. Due to the application prospects of CDs, it is anticipated that CDs will continue to emerge as an important tool for vector development, and will play significant roles in facilitating non-viral gene delivery in the forthcoming decades. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:401 / 411
页数:11
相关论文
共 50 条
  • [41] Development of non-viral vectors for systemic gene delivery
    Liu, F
    Huang, L
    JOURNAL OF CONTROLLED RELEASE, 2002, 78 (1-3) : 259 - 266
  • [42] The Development of Functional Non-Viral Vectors for Gene Delivery
    Patil, Suryaji
    Gao, Yong-Guang
    Lin, Xiao
    Li, Yu
    Dang, Kai
    Tian, Ye
    Zhang, Wen-Juan
    Jiang, Shan-Feng
    Qadir, Abdul
    Qian, Ai-Rong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [43] Non-viral gene delivery for p53
    Pirollo, KF
    Xu, L
    Chang, EH
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2000, 2 (02) : 168 - 175
  • [44] Non-viral Gene Delivery and Therapeutics Targeting to Brain
    Liu, Yang
    Huang, Rongqin
    Jiang, Chen
    CURRENT NANOSCIENCE, 2011, 7 (01) : 55 - 70
  • [45] Non-viral gene delivery to atelectatic and ventilated lungs
    Stammberger, U
    Uduehi, AN
    Kubisa, B
    Roth, T
    Schmid, RA
    ANNALS OF THORACIC SURGERY, 2002, 73 (02): : 432 - 436
  • [46] Non-viral Gene Delivery Methods for Bone and Joints
    Gantenbein, Benjamin
    Tang, Shirley
    Guerrero, Julien
    Higuita-Castro, Natalia
    Salazar-Puerta, Ana I.
    Croft, Andreas S.
    Gazdhar, Amiq
    Purmessur, Devina
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8 (08):
  • [47] Gemini nanoparticles as non-viral gene delivery systems
    Foldvari, M.
    Badea, I
    Wettig, S.
    Verrall, R.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2006, 2 (04) : 271 - 271
  • [48] Targeting tumors with non-viral gene delivery systems
    Ogris, M
    Wagner, E
    DRUG DISCOVERY TODAY, 2002, 7 (08) : 479 - 485
  • [49] Non-viral cancer gene therapy: Beyond delivery
    S Akhtar
    Gene Therapy, 2006, 13 (9) : 739 - 740
  • [50] Non-viral delivery of ribozymes for cancer gene therapy
    Kashani-Sabet, M
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (11) : 1749 - 1755